Pulsenmore Ltd. (PLSM)
NASDAQ: PLSM · Real-Time Price · USD
6.00
+0.20 (3.45%)
Feb 11, 2026, 3:29 PM EST - Market open
Pulsenmore Revenue
Pulsenmore had revenue of 4.00M ILS in the half year ending June 30, 2025, with 64.57% growth. This brings the company's revenue in the last twelve months to 9.31M, up 14.82% year-over-year. In the year 2024, Pulsenmore had annual revenue of 9.66M with 56.12% growth.
Revenue (ttm)
9.31M ILS
Revenue Growth
+14.82%
P/S Ratio
13.56
Revenue / Employee
160,517 ILS
Employees
58
Market Cap
37.48M USD
Revenue Chart
* This company reports financials in ILS.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.66M | 3.47M | 56.12% |
| Dec 31, 2023 | 6.19M | -4.63M | -42.78% |
| Dec 31, 2022 | 10.81M | 9.24M | 585.30% |
| Dec 31, 2021 | 1.58M | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TELA Bio | 77.06M |
| Myomo | 41.64M |
| Cytosorbents | 36.98M |
| Baird Medical Investment Holdings | 31.86M |
| electroCore | 29.84M |
| Spectral AI | 23.17M |
| Elutia | 21.75M |
| NeuroOne Medical Technologies | 12.10M |
PLSM News
- 2 days ago - Pulsenmore Builds U.S. Momentum with Another Commercial Engagement Following FDA Clearance - PRNewsWire
- 9 days ago - Pulsenmore Announces First Commercial Engagement with a Leading U.S.-Based Medical Center - PRNewsWire
- 16 days ago - Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation - PRNewsWire
- 21 days ago - Pulsenmore To Commence Trading on Nasdaq as It Expands FDA-authorized Home Prenatal Ultrasound Devices in the U.S. - PRNewsWire